Rainbow Children’s Medicare Limited has announced its financial results for the quarter and year ended March 31, 2026. Along with the financial disclosures, the company has recommended a final dividend of ₹3.50 per equity share for the fiscal year. Furthermore, the Board has approved the reappointment of key leadership figures, including the Chairman and Managing Director, and scheduled the 28th Annual General Meeting for July 29, 2026.
Financial Performance and Dividend Payout
The company successfully concluded its financial review for the quarter and the full fiscal year ending March 31, 2026. Following the approval of the standalone and consolidated financial results, the Board has recommended a final dividend of ₹3.50 per equity share, representing a 35% payout on the face value of ₹10 per share. The dividend payment remains subject to shareholder approval at the upcoming 28th Annual General Meeting.
Leadership Reappointments
The Board has approved the reappointment of several key leaders for a fresh five-year term, effective from August 11, 2026, until August 10, 2031:
- Dr. Ramesh Kancharla: Reappointed as Chairman and Managing Director.
- Dr. Dinesh Kumar Chirla: Reappointed as Whole Time Director.
Additionally, the Board has extended the terms of Independent Directors Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati for a second five-year term, ensuring continuity in the company’s governance and strategic oversight.
Governance and Audits
In addition to leadership changes, the company has officially reappointed M/s. Lavanya & Associates LLP as the Cost Auditors for the 2026-27 financial year. The company has set July 21, 2026, as the Record Date to determine shareholder eligibility for the proposed final dividend and for participation in the Annual General Meeting, which will be conducted via Video Conferencing.
Source: BSE
